PMGC Holdings Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $2.5M
- Price
- $3.14
- % Change (Daily % change from the live per-ticker quote feed.)
- -3.98%
- Volume
- 19.9K
About
PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations, the company also engages in medical scientific research and development and manages various investment firms. Formerly known as Elevai Labs, Inc., the organization adopted its current name, PMGC Holdings Inc., in December 2024. Established in 2020, PMGC Holdings Inc. maintains its headquarters in Newport Beach, California.
Quick stats
Shares outstanding809.6K
Computed float454.4K
Float / shares56.1%
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001840563
Websitehttps://pmgcholdings.com
AI Summary
AI-generated1/38
minorneutralother
PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Strategy
PMGC Holdings announced the completion of a $100 million SPAC IPO for NorthStrive Acquisition Corp. I (Nasdaq: NSAI), the first vehicle in its new SPAC sponsorship franchise.
PMGC holds a sponsor position of approximately 2.7 million shares, roughly 21.4% of the SPAC's Class A shares on an as-converted basis, and has already incorporated Northstrive Acquisition Corp. II as part of a planned repeatable platform.
The SPAC will target manufacturers in aerospace and defense, industrial technology, and critical supply chains, though no target has been selected and the company cautions there is no assurance any business combination will close or generate value.
Red flags
- No business combination target selected yet
- Release explicitly warns of additional organizational, legal, accounting and regulatory expenses and management demands
- No assurance any sponsored SPAC completes a business combination or creates shareholder value